Sun Pharmaceutical Industries submits press release

01 Aug 2019 Evaluate

Sun Pharmaceutical Industries has informed about submission of its Press Release relating to regulatory filing of Tildrakizumab in Japan, which the company shall be releasing after sending this letter. 

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1757.35 -38.30 (-2.13%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×